Advanced Search: EGFR

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.



Phase I/II study exploring the safety and efficacy of combining APL-101 with frontline osimertinib in patients with EGFR-mutated metastatic non-small cell lung cancer (NSCLC)